WallStSmart

Cross Country Healthcare Inc (CCRN)vsThe Ensign Group Inc (ENSG)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

The Ensign Group Inc generates 448% more annual revenue ($5.49B vs $1.00B). ENSG leads profitability with a 6.9% profit margin vs -9.8%. ENSG appears more attractively valued with a PEG of 1.34. ENSG earns a higher WallStSmart Score of 62/100 (C+).

CCRN

Hold

36

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.7Quality: 9.0
Piotroski: 4/9Altman Z: 4.25

ENSG

Buy

62

out of 100

Grade: C+

Growth: 8.0Profit: 6.0Value: 4.7Quality: 6.0
Piotroski: 4/9Altman Z: 2.15
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCRNUndervalued (+37.2%)

Margin of Safety

+37.2%

Fair Value

$13.16

Current Price

$13.25

$0.09 discount

UndervaluedFair: $13.16Overvalued
ENSGSignificantly Overvalued (-39.9%)

Margin of Safety

-39.9%

Fair Value

$151.53

Current Price

$182.21

$30.68 premium

UndervaluedFair: $151.53Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCRN3 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.2510/10

Safe zone — low bankruptcy risk

ENSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
17.3%8/10

17.3% revenue growth

Areas to Watch

CCRN4 concerns · Avg: 2.3/10
Market CapQuality
$428.06M3/10

Smaller company, higher risk/reward

PEG RatioValuation
12.622/10

Expensive relative to growth rate

Return on EquityProfitability
-31.5%2/10

ROE of -31.5% — below average capital efficiency

Revenue GrowthGrowth
-17.8%2/10

Revenue declined 17.8%

ENSG2 concerns · Avg: 3.5/10
P/E RatioValuation
26.6x4/10

Moderate valuation

Profit MarginProfitability
6.9%3/10

6.9% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : CCRN

The strongest argument for CCRN centers on Price/Book, Debt/Equity, Altman Z-Score.

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 17.3% demonstrates continued momentum. PEG of 1.34 suggests the stock is reasonably priced for its growth.

Bear Case : CCRN

The primary concerns for CCRN are Market Cap, PEG Ratio, Return on Equity.

Bear Case : ENSG

The primary concerns for ENSG are P/E Ratio, Profit Margin.

Key Dynamics to Monitor

CCRN profiles as a turnaround stock while ENSG is a growth play — different risk/reward profiles.

ENSG carries more volatility with a beta of 0.66 — expect wider price swings.

ENSG is growing revenue faster at 17.3% — sustainability is the question.

ENSG generates stronger free cash flow (119M), providing more financial flexibility.

Bottom Line

ENSG scores higher overall (62/100 vs 36/100) and 17.3% revenue growth. CCRN offers better value entry with a 37.2% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cross Country Healthcare Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Cross Country Healthcare, Inc. provides talent management and other consulting services for healthcare clients in the United States. The company is headquartered in Boca Raton, Florida.

Visit Website →

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Want to dig deeper into these stocks?